Related by context. Frequent words. (Click for all words.) 72 HGS ETR1 70 MGCD# [001] 69 AP# [003] 67 antitumor activity 67 kinase inhibitor 67 elesclomol 66 INGN 66 antitumor 66 CYT# 66 MDV# 66 hematological malignancies 66 HspE7 66 voreloxin 66 bortezomib 65 preclinical studies 65 Atiprimod 65 Phase Ib 65 RDEA# 65 CTCE 64 chemotherapeutic agent 64 XL# [003] 64 gemcitabine 64 Phase 1b 64 pharmacodynamic 64 Phase 2a trial 64 chemotherapeutics 64 ISIS # 64 pharmacodynamics 64 ENMD 63 pralatrexate 63 HDAC inhibitors 63 Preclinical studies 63 Perifosine 63 temozolomide 63 TNFerade 63 ALN VSP 63 tesetaxel 63 anti angiogenic 63 immunomodulatory 63 RG# [001] 63 dose escalation trial 62 Phase 2b clinical 62 blinatumomab 62 daclizumab 62 PLX# 62 solid tumors 62 TREANDA 62 anticancer agents 62 carfilzomib 62 potent inhibitor 62 perifosine 62 humanized monoclonal antibody 62 Marqibo 62 PF # [001] 62 IMGN# 62 chemotherapeutic agents 62 cytotoxic 61 INCB# [002] 61 doxorubicin 61 hematologic malignancies 61 FTY# 61 preclinical 61 ARRY 61 AZD# 61 picoplatin 61 cutaneous T cell 61 T DM1 61 MGCD# [002] 61 Azixa 61 GM CSF 61 taxanes 60 kinase inhibitors 60 CUDC 60 eculizumab 60 dasatinib 60 AACR NCI EORTC 60 immunotherapeutic 60 Phase 2b trial 60 anticancer 60 trastuzumab 60 HDAC 60 HDAC inhibitor 60 cytarabine 60 topotecan 60 erlotinib 60 MLN# 60 cytotoxicity 60 Hedgehog pathway 60 Phase 2a clinical 60 pemetrexed 60 resistant ovarian cancer 60 phase IIb 60 dose escalation 59 dose limiting toxicities 59 Phase IIa trial 59 TLR9 59 ONCONASE 59 preclinical models 59 myelofibrosis 59 pharmacokinetic profile 59 CRx